This is a synthetic peptide designed for use in combination with anti-KRT17 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
KRT17
Reaktivität: Human, Hund, Kaninchen, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
KRT17
(Keratin 17 (KRT17))
Synonyme
K17 Peptide, Krt1-17 Peptide, PC Peptide, PC2 Peptide, PCHC1 Peptide, Ka17 Peptide, KRT17 Peptide, krt16 Peptide, si:dkeyp-113d7.7 Peptide, KRT14 Peptide, keratin 17 Peptide, keratin 17 L homeolog Peptide, keratin 17, type I Peptide, keratin, type I cytoskeletal 17 Peptide, Krt17 Peptide, KRT17 Peptide, krt17 Peptide, krt17.L Peptide, LOC100737113 Peptide, LOC102177275 Peptide
Hintergrund
This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.